Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
01 2Pharmaceutical Works POLPHARMA
02 1Dr.Reddy's Laboratories Limited
03 1Assia Chemical Industries Ltd - Teva Tech Site
04 1Aurobindo Pharma Limited
05 1Cadila Pharmaceuticals Limited
06 1Cipla Ltd.
07 1Ipca Laboratories Limited
08 1Jubilant Pharmova Limited
09 1MYLAN LABORATORIES LIMITED
10 1Minsheng Group Shaoxing Pharmaceutical Co., LTD.
01 1ALENDRONATE ACID
02 3ALENDRONATE SODIUM
03 1ALENDRONATE SODIUM TRIHYDRATE
04 5Alendronate Sodium
05 1alendronate sodium
01 1China
02 6India
03 1Israel
04 2Poland
05 1U.S.A
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
NDC Package Code : 12658-0568
Start Marketing Date : 1999-11-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-874
Start Marketing Date : 2006-12-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
NDC Package Code : 12658-0612
Start Marketing Date : 1999-11-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (2kg/2kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63415-0071
Start Marketing Date : 2019-08-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65691-0056
Start Marketing Date : 2007-07-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7525
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1157
Start Marketing Date : 2013-08-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1134
Start Marketing Date : 2009-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13371-111
Start Marketing Date : 2018-01-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-683
Start Marketing Date : 2015-02-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Fosamax manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosamax, including repackagers and relabelers. The FDA regulates Fosamax manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosamax API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fosamax manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fosamax supplier is an individual or a company that provides Fosamax active pharmaceutical ingredient (API) or Fosamax finished formulations upon request. The Fosamax suppliers may include Fosamax API manufacturers, exporters, distributors and traders.
click here to find a list of Fosamax suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fosamax as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fosamax API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fosamax as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fosamax and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fosamax NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fosamax suppliers with NDC on PharmaCompass.
We have 10 companies offering Fosamax
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
